NirvaMed, Inc, based in Minneapolis, MN, is a medical device company founded by Dr. Pramote Hochareon, a research scientist with a background in heart arrhythmia detection and heart failure monitors. Driven by the need for effective treatment options for heart attack survivors, NirvaMed has developed a novel medical device that delivers heart cooling therapy quickly and efficiently to patients undergoing angioplasty. With promising preclinical results and technological advancements, NirvaMed is dedicated to reducing long-term complications from heart attacks and improving the standard of care for heart attack patients.
NirvaMed's innovative approach and commitment to advancing the field of heart cooling treatment have positioned the company for its next stage, a First-in-Human clinical study. By significantly reducing heart muscle damage, NirvaMed's technology holds the potential to enhance the quality of life for heart attack survivors and change the landscape of heart attack treatment. Please note that the NirvaMed device is currently for investigational use only and not yet commercially available.
Generated from the website